Cargando…
Pembrolizumab-Induced Isolated Cranial Neuropathy: A Rare Case Report and Review of Literature
Introduction: Anti-PD1 agents are widely used in the treatment of solid tumors. This has prompted the recognition of a class of immune-related adverse events (irAEs), due to the activation of autoimmune T-cells. Pembrolizumab is an anti-PD1 agent, which has been related to an increased risk of vario...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144636/ https://www.ncbi.nlm.nih.gov/pubmed/34046006 http://dx.doi.org/10.3389/fneur.2021.669493 |